Stock 7777 3-D MATRIX, LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials 3-D Matrix, Ltd.

Equities

7777

JP3410730000

Biotechnology & Medical Research

Delayed Japan Exchange
Other stock markets
 02:00:00 2024-04-30 am EDT 		5-day change 1st Jan Change
120 JPY +0.84% Intraday chart for 3-D Matrix, Ltd. +1.69% -14.29%
Apr. 04 3-D Matrix, Ltd. announced that it has received ¥22.62 million in funding from CVI Investments, Inc. CI
Mar. 19 3-D Matrix, Ltd. announced that it expects to receive ¥22.62 million in funding from CVI Investments, Inc. CI

Valuation

Fiscal Period: April 2018 2019 2020 2021 2022 2023
Capitalization 1 17,337 18,897 11,985 11,491 18,944 9,967
Enterprise Value (EV) 1 16,625 18,944 12,727 11,811 19,761 13,170
P/E ratio -8.9 x -6.93 x -3.64 x -5.22 x -9.3 x -3.87 x
Yield - - - - - -
Capitalization / Revenue 76 x 57.6 x 17.8 x 11.2 x 12.6 x 4.31 x
EV / Revenue 72.9 x 57.8 x 18.9 x 11.5 x 13.1 x 5.69 x
EV / EBITDA - - - - - -
EV / FCF -11.9 x -12.3 x -9.99 x -4.79 x -9.8 x -3.8 x
FCF Yield -8.38% -8.11% -10% -20.9% -10.2% -26.3%
Price to Book 7.87 x 12.5 x 25.3 x 6.93 x 13.1 x 19.3 x
Nbr of stocks (in thousands) 23,979 27,995 31,876 44,366 54,752 63,484
Reference price 2 723.0 675.0 376.0 259.0 346.0 157.0
Announcement Date 7/26/18 7/26/19 7/31/20 7/30/21 7/28/22 7/27/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: April 2018 2019 2020 2021 2022 2023
Net sales 1 228 328 672 1,024 1,506 2,314
EBITDA - - - - - -
EBIT 1 -1,875 -2,268 -2,536 -2,649 -2,736 -3,158
Operating Margin -822.37% -691.46% -377.38% -258.69% -181.67% -136.47%
Earnings before Tax (EBT) 1 -1,865 -2,553 -3,095 -2,011 -1,893 -2,443
Net income 1 -1,866 -2,554 -3,096 -2,012 -1,894 -2,445
Net margin -818.42% -778.66% -460.71% -196.48% -125.76% -105.66%
EPS 2 -81.25 -97.38 -103.4 -49.64 -37.19 -40.62
Free Cash Flow 1 -1,394 -1,535 -1,274 -2,466 -2,016 -3,462
FCF margin -611.35% -468.1% -189.66% -240.83% -133.83% -149.62%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 7/26/18 7/26/19 7/31/20 7/30/21 7/28/22 7/27/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: April 2020 S1 2021 S1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3
Net sales 1 316 472 640 360 423 984 574 827 1,836 1,148
EBITDA - - - - - - - - - -
EBIT 1 -1,274 -1,176 -1,372 -658 -768 -1,632 -705 -645 -1,214 -404
Operating Margin -403.16% -249.15% -214.38% -182.78% -181.56% -165.85% -122.82% -77.99% -66.12% -35.19%
Earnings before Tax (EBT) 1 -1,475 -1,087 -1,241 -828 -523 -379 -1,701 101 33 -578
Net income 1 -1,475 -1,087 -1,242 -828 -524 -380 -1,702 8 -139 -560
Net margin -466.77% -230.3% -194.06% -230% -123.88% -38.62% -296.52% 0.97% -7.57% -48.78%
EPS 2 -50.63 -28.14 -26.31 -15.36 -9.240 -6.550 -28.61 0.1300 -2.050 -7.780
Dividend per Share - - - - - - - - - -
Announcement Date 12/13/19 12/15/20 12/14/21 3/15/22 9/14/22 12/13/22 3/17/23 9/13/23 12/13/23 3/13/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: April 2018 2019 2020 2021 2022 2023
Net Debt 1 - 47 742 320 817 3,203
Net Cash position 1 712 - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -1,394 -1,535 -1,275 -2,466 -2,016 -3,462
ROE (net income / shareholders' equity) -77.6% -138% -312% -189% -121% -247%
ROA (Net income/ Total Assets) -35.7% -39.2% -44% -50% -37.5% -34.5%
Assets 1 5,221 6,511 7,039 4,024 5,050 7,083
Book Value Per Share 2 91.80 53.90 14.80 37.40 26.40 8.140
Cash Flow per Share 2 48.50 64.20 33.20 25.60 51.70 18.20
Capex 1 18 12 5 18 7 16
Capex / Sales 7.89% 3.66% 0.74% 1.76% 0.46% 0.69%
Announcement Date 7/26/18 7/26/19 7/31/20 7/30/21 7/28/22 7/27/23
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
3-D MATRIX, LTD. Stock 3-D Matrix, Ltd.
-14.29% 60.27M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.77% 42.86B
LONZA GROUP AG Stock Lonza Group AG
+47.02% 41.36B
MODERNA, INC. Stock Moderna, Inc.
+12.24% 42.74B
CELLTRION, INC. Stock Celltrion, Inc.
-8.83% 27.68B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+7.44% 25.15B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-23.01% 18.63B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+30.56% 12.37B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-1.82% 11.92B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+8.35% 11.21B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. 7777 Stock
  4. Financials 3-D Matrix, Ltd.